Regulatory & market intelligence for alternative tobacco & nicotine products
Tobacco corporations seem to be accelerating their commitment towards more sustainable businesses, investing in projects to reduce environmental harm caused by tobacco-alternative devices
Philip Morris International (PMI) has concluded its controversial £1.1bn takeover of UK health firm Vectura, along with that of the Danish oral-products manufacturer Fertin Pharma
Swedish Match has announced that the company is to become 100% smoke-free by next year with the separation of its cigar business in the US, a decision that is likely to have an impact in the market
All the stories from the TobaccoIntelligence regulatory Live Alerts in one user-friendly database, updated every month.
This regulatory tool consolidates all of our global regulatory Live Alerts, collected in Excel database format, allowing you to filter information by date, region, country and legislative area.
The board of UK health firm Vectura has recommended that shareholders support the £1.2bn takeover bid from tobacco giant PMI
The proposal of Philip Morris International (PMI) to acquire inhaled drug delivery company Ventura for $1.2bn has alerted the UK government, which can block the deal if it sees any major public interest reason to do so
JTI posted positive numbers in the first half of the year, with good performance from its reduced-risk products and improvement in its full-year guidance after the launch of Ploom X
Jacek Olczak, CEO of Philip Morris International (PMI), says the company could stop selling combustible cigarettes in the UK within a decade
British American Tobacco (BAT) has posted a 0.8% global decrease in revenue for the first half of the year, while the performance of its new category portfolio rose by 40.4%
The latest figures from Swedish Match show continued momentum in smoke-free tobacco alternatives, with nicotine pouches “the driving force”
Philip Morris International (PMI) has always been one of the frankest tobacco companies when it comes to speaking of the smoke-free future – now it is taking positive steps in a bold new direction
PMI’s acquisition of Fertin Pharma, a Danish manufacturer of gums and other oral products, indicates the company’s strategy to ensure “corporate survival” in the tobacco-alternatives sector, experts believe
British American Tobacco (BAT) is removing its Velo nicotine pouches from the German market because of a lack of clarity over their regulation both nationally and in the country’s regional states
Italy’s antitrust regulator has opened formal procedures against British American Tobacco (BAT) for using influencers to promote an advertising campaign for Glo Hyper, and it could cost the manufacturer millions
Imperial Brands’ earnings in the first half of the year jumped 6.1% to £15.57bn in the midst of a process to implement a new company strategy towards tobacco alternatives
Imperial Brands has announced that it expects to deliver its yearly objectives for 2021 and expressed optimism about the performance of its heated tobacco device Pulze
PMI is spreading optimism about its “beyond nicotine” portfolio, aiming to reach $1bn revenue from tobacco-alternatives in less than five years’ time, with an expected increase in the demand of heated tobacco consumables
Altria has posted positive numbers for the last quarter of 2020 despite the coronavirus pandemic, with a good performance for its oral portfolio but unknown figures for Iqos in the US
Imperial Brands has announced a substantial shift in strategy towards its next-generation products category, with a focus on investment in heated tobacco in Europe over the next five years
Philip Morris International (PMI) is to have a new CEO, with Jacek Olczak taking over from André Calantzopoulos after the annual shareholder meeting in May
Apart from the obvious, what has 2020 brought us? And in particular, what has it brought to the world of alternative tobacco and tobacco alternatives?
British American Tobacco (BAT) is planning to invest up to $25m in a factory in Kenya to manufacture Lyft nicotine pouches – under regulatory scrutiny from officials in the country
The US Food and Drug Administration (FDA) has issued a marketing order authorising the sale of Philip Morris International (PMI)’s IQOS 3 holder and charger
Use our newly updated directory of stakeholders in the International tobacco alternatives world to find the most relevant organisations in key markets, with full Web, email, phone and address details.
Imperial Brands has revealed that net revenue from its next-generation portfolio declined by 27% in the year to September and announced that it will take a “more prudent approach” from now on
Altria’s oral tobacco portfolio drove the numbers of the Big Tobacco company, amid “uncertainties” caused by the COVID-19 pandemic
While Philip Morris International (PMI)’s earnings fell slightly in the third quarter of the year due to the ongoing COVID-19 challenges, shipments of the company’s heated tobacco units were up by 18.7%
Imperial Brands has revealed that the company’s net revenue for its next-generation portfolio is around 30% lower than 2019, while the overall company revenue looks set to remain flat this year
While the Philippines debates regulations to restrict tobacco alternatives, PMFTC, the Philippine affiliate of Philip Morris International (PMI), has opened its first four IQOS stores in the Manila area
Reynolds American has submitted a premarket tobacco product application (PMTA) to the US Food and Drug Administration (FDA) for its Velo nicotine lozenges to remain on the market after September
KT&G heated tobacco products are available outside South Korea for the first time after Philip Morris International (PMI) began marketing them in Russia
Japan Tobacco International (JTI) is to increase the price of some of its heated tobacco consumables in Japan from 1st October
BAT’s revenue from its smokeless portfolio increased by 5.7% to £9.4bn ($12.3bn) in the first six months of the year, helped by higher revenue in the modern oral segment
Altria has reported net revenue to be down by 3.8% in Q2 2020 due to the decrease of the traditional tobacco business, though a further drop was prevented thanks to the good performance of its smokeless products in the US
The Japanese Consumer Affairs Agency has imposed a fine of JPY552m ($5.1m) on Philip Morris Japan (PMJ) for misleading advertising of IQOS when discounts were extended beyond the allotted date
British American Tobacco (BAT) is pushing back to 2025 its goal of £5bn in revenues from its next-generation portfolio amid the COVID-19 pandemic and a decrease in heat-not-burn (HnB) business
The Altria Group has filed a lawsuit for patent infringement against RJ Reynolds Vapor Co, a subsidiary of Reynolds American, over its Velo smokeless product
Japan Tobacco (JT) and Philip Morris International (PMI) are cutting the prices of their heat-not-burn (HnB) devices in Japan and planning new product launches amid the coronavirus pandemic
Big Tobacco manufacturers are expecting the effects of COVID-19 to hit hard in the second half of the year, despite a strong performance in the first quarter
Swedish Match’s sales of smoke-free products boomed in the first quarter of 2020, with the segment recording a 35% year-on-year increase to SEK2.508bn (€234m)
British American Tobacco is suing Big Tobacco rival Philip Morris International in the US and in Europe for allegedly infringing its patents with its popular heated tobacco device IQOS
Philip Morris International is braced for a significant dip in sales and use of its heated-tobacco device IQOS over the rest of 2020, with retail and travel restrictions currently imposed in nearly every country
The US tobacco industry is resisting another attempt by the FDA to impose graphic health warnings, claiming in a lawsuit that mandatory warnings would violate their rights under the First Amendment
The US International Trade Commission (USITC) is looking into a possible infringement of the patent for a nicotine pouch product, following a claim led by Swedish Match North America
Philip Morris International (PMI)’s chief financial officer, Martin King, has been promoted to the newly created role of CEO for PMI America in a bid to further develop the company’s smoke-free segment
British American Tobacco (BAT)’s “modern oral” portfolio has been one of the main drivers helping the company achieve good results in 2019 for its next-generation products category, which overall increased globally by 36.9%
What benefit might there be in very low nicotine combustible cigarettes? That is the essential question the US FDA must answer in assessing a modified risk tobacco product (MRTP) application from 22nd Century Group for its VLN products
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the TobaccoIntelligence team.
